VT-1161: Phase IIb started

Viamet began the double-blind, placebo-controlled, U.S. Phase IIb RENOVATE trial to evaluate 300 and 600 mg oral VT-1161 once daily for 2 weeks followed by once weekly for 10 or 22 weeks in about 250 ...